R Warnke

5.0k total citations · 2 hit papers
32 papers, 4.1k citations indexed

About

R Warnke is a scholar working on Pathology and Forensic Medicine, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, R Warnke has authored 32 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pathology and Forensic Medicine, 15 papers in Immunology and 13 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in R Warnke's work include Lymphoma Diagnosis and Treatment (20 papers), Monoclonal and Polyclonal Antibodies Research (13 papers) and Chronic Lymphocytic Leukemia Research (9 papers). R Warnke is often cited by papers focused on Lymphoma Diagnosis and Treatment (20 papers), Monoclonal and Polyclonal Antibodies Research (13 papers) and Chronic Lymphocytic Leukemia Research (9 papers). R Warnke collaborates with scholars based in United States, Nigeria and United Kingdom. R Warnke's co-authors include Ronald Levy, Gary S. Wood, J Sklar, Juan Rosaí, Michael L. Cleary, Robert I. Fox, Jeanette Dilley, James B. Rottman, Joseph Haimovich and Nancy Ruffing and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

R Warnke

32 papers receiving 3.8k citations

Hit Papers

The chemokine receptor CC... 1981 2026 1996 2011 1999 1981 200 400 600

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
R Warnke 1.7k 1.6k 1.3k 810 758 32 4.1k
E. Kaiserling 1.8k 1.0× 1.5k 0.9× 1.3k 1.0× 642 0.8× 284 0.4× 212 5.2k
D Y Mason 1.5k 0.9× 1.1k 0.7× 1.2k 1.0× 548 0.7× 723 1.0× 32 5.1k
Harald Stein 1.1k 0.7× 1.9k 1.2× 1.5k 1.1× 672 0.8× 548 0.7× 53 4.0k
Harald Stein 1.1k 0.6× 1.1k 0.7× 1.2k 1.0× 526 0.6× 592 0.8× 20 4.1k
A K Ghosh 1.2k 0.7× 788 0.5× 1.2k 0.9× 345 0.4× 517 0.7× 31 4.1k
S Poppema 1.7k 1.0× 1.8k 1.2× 1.7k 1.3× 752 0.9× 629 0.8× 93 4.6k
Z. Abdulaziz 1.1k 0.6× 759 0.5× 871 0.7× 386 0.5× 580 0.8× 9 3.7k
Roland Repp 2.2k 1.3× 1.1k 0.7× 1.4k 1.1× 615 0.8× 1.7k 2.2× 85 4.3k
Jonathan W. Said 979 0.6× 1.4k 0.9× 1.1k 0.8× 475 0.6× 284 0.4× 70 3.5k
Horst Dürkop 1.7k 1.0× 1.6k 1.0× 1.2k 0.9× 422 0.5× 406 0.5× 58 3.9k

Countries citing papers authored by R Warnke

Since Specialization
Citations

This map shows the geographic impact of R Warnke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Warnke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Warnke more than expected).

Fields of papers citing papers by R Warnke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Warnke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Warnke. The network helps show where R Warnke may publish in the future.

Co-authorship network of co-authors of R Warnke

This figure shows the co-authorship network connecting the top 25 collaborators of R Warnke. A scholar is included among the top collaborators of R Warnke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Warnke. R Warnke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Advani, Ranjana H., Richard T. Hoppe, D. Baer, et al.. (2012). Efficacy of abbreviated Stanford V chemotherapy and involved-field radiotherapy in early-stage Hodgkin lymphoma: mature results of the G4 trial. Annals of Oncology. 24(4). 1044–1048. 17 indexed citations
2.
Rieger, Kerri E., et al.. (2010). ALK-negative systemic intravascular anaplastic large cell lymphoma presenting in the skin. Journal of Cutaneous Pathology. 38(2). 216–220. 18 indexed citations
4.
Campbell, James J., Guttorm Haraldsen, Junliang Pan, et al.. (1999). The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature. 400(6746). 776–780. 683 indexed citations breakdown →
5.
Advani, Ranjana H., R Warnke, Branimir I. Šikić, & Sandra J. Horning. (1997). Treatment of angioimmunoblastic T-cell lymphoma with cyclosporine. Annals of Oncology. 8(6). 601–603. 24 indexed citations
6.
Rivas, A, Curtis Ruegg, Reiner Laus, et al.. (1995). V7, a novel leukocyte surface protein that participates in T cell activation. I. Tissue distribution and functional studies.. The Journal of Immunology. 154(9). 4423–4433. 26 indexed citations
7.
Wood, Katrina, Gorm Pallesen, E. Ralfkiaer, et al.. (1993). Heterogeneity of CD3 antigen expression in T‐cell lymphoma. Histopathology. 22(4). 311–317. 12 indexed citations
8.
Bastard, Christian, Ruth Rimokh, Nicole Dastugue, et al.. (1990). CD30‐positive large cell lymphomas (‘Ki‐1 lymphoma’) are associated with a chromosomal translocation involving 5q35. British Journal of Haematology. 74(2). 161–168. 264 indexed citations
9.
Naumovski, Louie, et al.. (1989). SUP-HD1: a new Hodgkin's disease-derived cell line with lymphoid features produces interferon-gamma [see comments]. Blood. 74(8). 2733–2742. 45 indexed citations
11.
Smith, SD, R Morgan, R. T. Gemmell, et al.. (1988). Clinical and biologic characterization of T-cell neoplasias with rearrangements of chromosome 7 band q34. Blood. 71(2). 395–402. 51 indexed citations
12.
Lm, Weiss, et al.. (1987). Non-Hodgkin's lymphoma containing both B and T cell clones. Blood. 70(1). 287–292. 40 indexed citations
13.
Clayberger, Carol, et al.. (1987). ABSENCE OF CELL SURFACE LFA-1 AS A MECHANISM OF ESCAPE FROM IMMUNOSURVEILLANCE. The Lancet. 330(8558). 533–536. 120 indexed citations
14.
Carroll, William L., et al.. (1986). Idiotype variant cell populations in patients with B cell lymphoma.. The Journal of Experimental Medicine. 164(5). 1566–1580. 46 indexed citations
15.
Cleary, ML, et al.. (1984). Immunoglobulin gene rearrangements in hairy cell leukemia. Blood. 64(1). 99–104. 48 indexed citations
16.
Dvoretsky, Philip M., Graham R. Wood, Rona L. Levy, & R Warnke. (1982). T-lymphocyte subsets in follicular lymphomas compared with those in non-neoplastic lymph nodes and tonsils. Human Pathology. 13(7). 618–625. 91 indexed citations
17.
Engleman, Edgar G., R Warnke, Robert I. Fox, et al.. (1981). Studies of a human T lymphocyte antigen recognized by a monoclonal antibody.. Proceedings of the National Academy of Sciences. 78(3). 1791–1795. 307 indexed citations
18.
Warnke, R & Ronald Levy. (1980). Detection of T and B cell antigens hybridoma monoclonal antibodies: a biotin-avidin-horseradish peroxidase method.. Journal of Histochemistry & Cytochemistry. 28(8). 771–776. 300 indexed citations
19.
Warnke, R, NR Dunnick, Ronald A. Castellino, et al.. (1977). Clinical and surgical (laparotomy) evaluation of patients with non-Hodgkin's lymphomas.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 61(6). 981–92. 130 indexed citations
20.
Levy, Ronald, R Warnke, R. F. Dorfman, & Joseph Haimovich. (1977). The monoclonality of human B-cell lymphomas.. The Journal of Experimental Medicine. 145(4). 1014–1028. 226 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026